Patient initially identified September 19, 2019 as a Remarkable Responder;Patient has continued to experience a highly remarkable reduction in tumors […]
Full year 2019 preliminary revenues and adjusted profitability metrics in line with prior guidanceFull year 2020 forecast reflects continued growth […]